Myrio Tx
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6-16 Joseph St, Blackburn North, Victori...Website
www.myriotx.comRevenue
<$5 MillionIndustry
About Myrio Tx
Myrio Tx Org Chart
Is Myrio Tx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Myrio Tx is spiking on competitors!
Myrio Tx, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Myrio Tx recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Myrio Tx launches new products
Click to see if Myrio Tx had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Myrio Tx
Check if Myrio Tx has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Myrio Tx has new funding data
Recommended Actions
Find VP level buyers at Myrio Tx
Find 3 more new buyers
Compare Similar Companies to Myrio Tx
Compare insights from companies similar to Myrio Tx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Myrio Tx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Myrio Tx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Myrio Tx.
Myrio Tx Tech Stack
A closer look at the technologies used by Myrio Tx
Top Business Services Companies
Top companies in Canada by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Myrio Tx
Myrio Therapeutics is a Melbourne-based biotechnology company specializing in the development of innovative immuno-oncology therapies targeting intracellular proteins through its proprietary Retained Display (ReD) platform. Founded in 2009, the company focuses on creating high-precision antibodies that can effectively target diverse Human Leukocyte... Read More